Septerna (SEPN) Revenue (2023 - 2026)

Septerna (SEPN) recorded quarterly Revenue of $26.5 million in Q1 2026, up 9.88% quarter-over-quarter from $24.1 million in Q4 2025, and up 12000.46% on a YoY basis from N/an in Q1 2025.

Septerna (SEPN) Revenue (2023 - 2026) Analysis & Trends

Septerna's Revenue history runs 4 years deep, the most recent figure standing at $26.5 million for Q1 2026.

  • In Q1 2026, Revenue rose 12000.46% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $72.2 million (up 7293.24% YoY), while the FY2025 annual figure was $46.0 million, up 4174.51% from the prior year.
  • Revenue was $26.5 million for Q1 2026 at Septerna, up from $24.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $26.5 million in Q1 2026 to a low of $33000.0 in Q3 2023.
  • Historically, Revenue has averaged $6.7 million across 4 years, with a median of $219000.0 in 2025.
  • Biggest YoY gain for Revenue was 12113.07% in 2025; the steepest drop was 67.84% in 2025.
  • A 4-year view of Revenue shows it stood at $118000.0 in 2023, then surged by 79.66% to $212000.0 in 2024, then jumped by 11276.42% to $24.1 million in 2025, then gained by 9.88% to $26.5 million in 2026.
  • The last three Revenue figures came in at $26.5 million (Q1 2026), $24.1 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Septerna 1.62 Bn 1.62 Bn - 26.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.50 Mn
Dec 31, 2025 24.12 Mn
Sep 30, 2025 21.50 Mn
Jun 30, 2025 119,000.00
Mar 31, 2025 219,000.00
Dec 31, 2024 212,000.00
Sep 30, 2024 176,000.00
Jun 30, 2024 370,000.00
Mar 31, 2024 317,000.00
Dec 31, 2023 118,000.00
Sep 30, 2023 33,000.00